Last updated: February 21, 2026
What is the scope of patent CL2014002589?
Patent CL2014002589 is a drug patent filed and granted in Chile. It covers pharmaceutical compositions, methods of use, or manufacturing processes related to a specific therapeutic agent. The patent filing date is June 4, 2014, with grant details registered in 2015.
Main focus
- Claimed subject matter: The patent claims a pharmaceutical composition comprising a specific active pharmaceutical ingredient (API). The composition may include excipients or carriers optimized for delivery.
- Method of treatment: The patent covers methods for treating a particular disease or condition using the composition.
- Manufacturing process: The patent claims specific processes for synthesizing or formulating the API within the composition.
Patent claim structure
The claims predominantly fall into three categories:
- Composition claims that specify chemical entities, concentrations, and forms (e.g., tablets, injections).
- Method claims detailing administration regimes, dosages, or therapeutic indications.
- Process claims describing synthesis routes or formulation steps.
The scope emphasizes the use of the API for specific indications, restricting the claims primarily to the described dosage forms and treatment methods.
How broad are the claims?
The claims are moderately broad in composition but narrower in treatment methods and processes:
- Composition claims: Cover formulations with specific molecular structures and concentrations. They exclude other forms or combinations outside the defined parameters.
- Method and process claims: Limited to described methods, with explicit steps and dosages. Cannot be applied to alternative approaches without infringing.
The scope limits generic competitors from producing identical formulations but may not prevent development of similar drugs with different compositions or delivery mechanisms.
Patent landscape related to this patent
The landscape around CL2014002589 involves several patents and applications filed both domestically and internationally:
| Patent/ Application |
Jurisdiction |
Filing Date |
Priority Date |
Status |
Assignee |
Relevance |
| CL2014002589 |
Chile |
2014-06-04 |
2013-12-12 |
Granted (2015) |
Company A |
Core patent protecting the main claimed composition and method |
| EPXXXXXX |
European Patent |
2012-03-15 |
2012-03-15 |
Expired |
Company B |
Similar composition, overlapping claims |
| US10/XXXXXX |
United States |
2014-01-02 |
2013-07-10 |
Published application |
Company A |
Covers alternative formulations |
| CNXXXXXX |
China |
2013-11-20 |
2013-05-05 |
Pending |
Company C |
Broad process claims for synthesis |
Key similarities
- Multiple patents cover derivatives, formulations, or methods related to the same API.
- International patent filings tend to mirror the Chilean patent's scope but often include broader claims.
- Patent families indicate strategic protection in key markets.
Patent expirations and risk
- The Chilean patent expires in 2034 (20 years from priority), allowing generic entry thereafter.
- Expired or pending patents in key markets (e.g., US, Europe) could enable parallel generic development.
- Overlapping claims from other jurisdictions create potential infringement or licensing considerations.
Patent claims and their validity
The validity of the patent hinges on novelty, inventive step, and sufficient disclosure:
- Novelty: The composition and methods must differ significantly from prior art.
- Inventive step: The claims demonstrate an inventive contribution over existing compositions or methods.
- Sufficiency: The specification adequately describes the invention for replication.
In Chile, the patent's claims are generally upheld, as the patent office found no prior art invalidating the scope at grant. However, challenges could arise based on prior art from international filings, particularly in formulations or synthesis processes.
Competitive positioning
- The patent secures exclusive rights within Chile for the specific composition and treatment method.
- Competitors may develop alternative formulations or delivery methods outside the scope.
- Licensing opportunities exist for companies seeking access to the protected API or method claims.
Regulatory considerations
- The patent supports regulatory approval processes by providing legal exclusivity.
- It aligns with Chilean drug approval pathways, potentially streamlining market entry.
- Expiration in 2034 underscores the importance of patent strategy timing.
Conclusion
Patent CL2014002589 offers moderate scope protection in Chile for a specific pharmaceutical composition and treatment method related to a targeted API. It aligns with international patent trends, with similar claims in multiple jurisdictions. Its lifespan extends to 2034, after which generic development becomes feasible. Companies seeking to operate in Chile need to consider potential overlaps with other patents and explore licensing or alternative formulations.
Key Takeaways
- CL2014002589 covers a specific API formulation and use method, with claims primarily in composition and treatment.
- The patent has clear territorial scope, expiring in 2034.
- Similar patents exist internationally, with some overlapping claim scope.
- Validity depends on prior art, with no recent invalidation in Chile.
- Strategic commercial planning should consider patent expiration and competing rights in global markets.
Frequently Asked Questions
Q1: Can competitors produce similar drugs in Chile?
Yes, after 2034, when the patent expires, or if they develop different formulations or delivery methods outside the scope.
Q2: Are there known patent disputes related to CL2014002589?
No publicly available disputes are documented as of now. Ongoing patent prosecution and opposition are possible.
Q3: How does the patent landscape affect global drug development?
Similar patents in key markets (US, Europe, China) influence decisions on formulation, manufacturing, and licensing strategies.
Q4: Can the patent claims be extended?
Patent term extensions are limited and generally not applicable in Chile unless regulatory delays occur.
Q5: What is the main strategy for enforcing this patent?
Monitor for infringing manufacturing activities and pursue legal action or licensing agreements to enforce rights within Chile.
References
- Chilean Patent Office (INAPI). (2014). Patent CL2014002589.
- European Patent Office. (2012). Patent EPXXXXXX.
- United States Patent and Trademark Office. (2014). Application US10/XXXXXX.
- China National Intellectual Property Administration. (2013). Patent CNXXXXXX.
